Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trinity Biotech PLC TRIB

Trinity Biotech plc is an Ireland-based commercial stage biotechnology company. The Company is focused on human diagnostics and diabetes management solutions, including wearable biosensors. The Company develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market and has also entered the wearable biosensor industry. It intends to develop a range of biosensor devices and related services, starting with a continuous glucose monitoring product. Its products are used to detect infectious diseases and to quantify the level of Hemoglobin A1c and other chemistry parameters in serum, plasma and whole blood. The Company, through EpiCapture Limited, is also developing a non-invasive test for monitoring the risk of aggressive prostate cancer. The Company sells its products direct in the United States and through a network of international distributors.


NDAQ:TRIB - Post by User

Post by FalconProfit901on Nov 30, 2024 10:46am
22 Views
Post# 36338892

Is the Market Underestimating the Travel Bounce for $TRIP?

Is the Market Underestimating the Travel Bounce for $TRIP?The travel sector is heating up, and $TRIP has been looking a bit sleepy for the past year, but I’m wondering if we’re missing something here. Revenue growth is still there, and with the holidays coming up, I wouldn’t be shocked if we see a little bump in Q4 earnings. People are still planning trips, and $TRIP is one of the biggest platforms for that. I’m not saying it’s going back to $30, but at under $14, it’s not totally unreasonable to think there could be some upside. And speaking of potential moves, I’m also eyeing $BOLT—I’ve been hearing that stock might be ready to pop soon. Anyone else thinking this might be a solid swing play heading into year-end?
<< Previous
Bullboard Posts
Next >>